The healthcare landscape for glucose is evolving, and these patches represent a potential breakthrough. Unlike subcutaneous injections, this approach offers a less invasive way to provide GLP-1 drugs. These transdermal systems steadily release the medication through the skin offering a stable dose of the beneficial agent, which can enhance glucose